BLOG

FDA Warning on Xylazine: Mitigating Human Risk

FDA Warning on Xylazine: Mitigating Human Risk

FDA Warning on Xylazine: Mitigating Human Risk  | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...

read more
Company News
FRR’s NavigateSOM Software!

FRR’s NavigateSOM Software!

Pharma Solutions' NavigateSOM Software! On April 24th NavigateSOM was published in the Trademark Official Gazette! Pharma Solutions  launched a...

read more

Email Newsletter